|
Yale Cancer Biology Training Grant
|
5T32CA193200-03
|
$229,769
|
|
GLAZER, PETER
|
YALE UNIVERSITY
|
|
Whole-of-Community Systems Intervention for Youth Population Physical Activity
|
1R01CA215420-01A1
|
$512,891
|
|
DZEWALTOWSKI, DAVID
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
|
5K12CA167540-07
|
$810,000
|
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer
|
1R01CA214606-01A1
|
$370,707
|
|
RODRIGUEZ, GUSTAVO
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Validation and translation of a non-invasive, MR-guided breast cancer therapy
|
1R37CA224141-01
|
$513,511
|
|
PAYNE, ALLISON
|
UNIVERSITY OF UTAH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-07
|
$641,991
|
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
5R21CA216756-02
|
$224,460
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
5R21CA208921-02
|
$167,475
|
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
uSHEAR Technology for Cancer Cell Purificaiton
|
5R21CA202849-03
|
$225,649
|
|
GARCIA, ANDRES
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,788,723
|
$89,436
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
5R01CA184804-03
|
$387,731
|
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
Unlocking the Potential of PI3K Inhibition in CLL
|
5R01CA213442-02
|
$596,117
|
|
BROWN, JENNIFER
|
DANA-FARBER CANCER INST
|
|
University of Virginia Cancer Center Support Grant
|
2P30CA044579-26
|
$2,574,504
|
$25,745
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S1
|
$125,000
|
$1,250
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S2
|
$104,087
|
$1,041
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
Understanding Uncertainties in Radiomics Studies
|
5R21CA216572-02
|
$139,200
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Understanding and Improving Platinum Anticancer Drugs
|
5R01CA034992-36
|
$674,719
|
|
YILMAZ, OMER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
|
5R01CA204969-02
|
$320,959
|
|
NAGRATH, DEEPAK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
|
5R01CA154451-05
|
$506,176
|
|
HWANG, JOO
|
UNIVERSITY OF WASHINGTON
|
|
Treatment and Outcomes in Diabetic Breast Cancer Patients
|
5R01CA188353-04
|
$186,527
|
|
GOLD, HEATHER
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Translation addiction and targeting in colon cancer
|
1R01CA215481-01A1
|
$467,690
|
|
YU, JIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Transcription repression in prostate cancer
|
5R01CA112226-09
|
$402,563
|
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
|
5F30CA206291-03
|
$49,524
|
|
GURBANI, SAUMYA
|
EMORY UNIVERSITY
|
|
TOPAS - nBio, a Monte Carlo tool for radiation biology research
|
5R01CA187003-04
|
$266,317
|
|
SCHUEMANN, JAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$651,382
|
$13,028
|
Vocke, Cathy
|
CCR (NCI)
|
|
Thrombocytes in Cancer Immunity
|
5R01CA188419-04
|
$387,236
|
|
LI, ZIHAI
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
The Role of STAT2 in Flat Non-Polypoid Colorectal Neoplasia
|
5R03CA215929-02
|
$78,000
|
|
GAMERO, ANA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
The role of PLK1 in prostate cancer
|
5R01CA191002-03
|
$348,844
|
|
FU, ZHENG
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
The role of PCDH7 in lung cancer pathogenesis
|
5R01CA207763-02
|
$357,482
|
|
O'DONNELL, KATHRYN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The Role of JAK2 in ILEI-Induced Cancer Stem Cell Formation
|
5F30CA203269-03
|
$46,154
|
|
NOGUCHI, KEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
The Role of IDH1 Mutations in Gliomagenesis and Metabolism
|
5R01CA140316-08
|
$377,625
|
|
YAN, HAI
|
DUKE UNIVERSITY
|
|
The role of GPSM3 in tumor-promoting emergency myelopoiesis
|
5R01CA208354-02
|
$361,425
|
|
ZHANG, BIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of gene enhancer elements in colon cancer
|
2R01CA160356-06
|
$366,669
|
|
SCACHERI, PETER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
|
1R37CA214609-01A1
|
$366,000
|
|
GIBBONS, DON
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Role of DLST in Leukemogenesis
|
1R01CA215059-01A1
|
$377,437
|
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma
|
5R01CA182869-04
|
$345,918
|
|
HOUCHEN, COURTNEY
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair
|
5R01CA138835-09
|
$317,509
|
|
GREENBERG, ROGER
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Myc - miR-17-92 axis in colorectal cancers
|
5R01CA196299-04
|
$384,300
|
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
|
5R01CA214608-02
|
$410,426
|
|
FISCHER, ERIC
|
DANA-FARBER CANCER INST
|
|
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma
|
1R01CA216922-01A1
|
$426,489
|
|
HENSKE, ELIZABETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Lifecycle of Health Data: Polices and Practices
|
1R01CA214829-01A1
|
$621,572
|
|
KARDIA, SHARON
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The inhibitory network between EZH2 and PARP1 in triple-negative breast cancer
|
5R01CA208257-02
|
$369,431
|
|
CAO, QI
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
The Impact of Tobacco Control Policies on Health Equity in the United States
|
1R37CA214787-01A1
|
$518,400
|
|
FLEISCHER, NANCY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The identification of genetic determinants of melanoma recurrence
|
5R01CA187060-04
|
$629,257
|
|
KIRCHHOFF, TOMAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The epigenetic mechanism of long non-coding RNA in cancer
|
5R01CA190415-04
|
$366,000
|
|
ZHANG, LIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
The E2F1 Post-Translational Modification Code
|
1R01CA214723-01A1
|
$444,362
|
|
JOHNSON, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
|
5R01CA204167-03
|
$674,466
|
|
LEWIS, JASON
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention
|
1R37CA214785-01A1
|
$730,499
|
|
BLINDER, VICTORIA
|
SLOAN-KETTERING INST CAN RESEARCH
|
Total relevant funding to Testes for this search: $2,876,459
|